Ind-Swift Laboratories has entered into a Joint Venture, which shall be operated through a newly incorporated entity viz MJM Remedies, where the Company shall have 75% stake and rest 25% stake shall be held by Ramesh Mehta. The new joint venture will explore the opportunities in the pharmaceutical field. MJM Remedies belongs to pharmaceutical industry.
Ind-Swift Laboratories is global manufacturer of Active Pharmaceutical Ingredients (API), Intermediates and formulations (through group collaboration).
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1669.90 |
| Dr. Reddys Lab | 1234.40 |
| Cipla | 1232.35 |
| Zydus Lifesciences | 936.50 |
| Lupin | 2328.65 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: